London court throws out lawsuit against Google over medical records
Google on Friday defeated a lawsuit brought on behalf of 1.6 million people over medical records provided to the U.S. tech giant by a British hospital trust.
Source: reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ODNTRJHOVFO73E7BOL5SL476NU.jpg)
Page 40 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Heca Today - Breaking & Trending Today
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XDLS6UMELVMWPL6SDAXL7CAI2I.jpg)
Thermo Fisher's preeclampsia blood test wins FDA clearance
The U.S. Food and Drug Administration (FDA) has cleared Thermo Fisher Scientific Inc's test, the first of its kind in the country, to detect women with risk of severe preeclampsia, the company said on Friday.
Source: reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CALQPPEQBJIB5GKD7GOIEUC2Y4.jpg)
Berlusconi says his 'nightmare is over' after 6-week hospital stay
Former Italian Prime Minister Silvio Berlusconi smiled from a car as he left Milan's San Raffaele hospital on Friday, returning home after six weeks of treatment for a lung infection linked to chronic leukaemia.
Source: reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PXQ3JLH6AFNQZNCFVKYL63N7KA.jpg)
US FDA approves Genmab-AbbVie's blood cancer therapy
The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab's blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday.
Source: reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ERJFCUQHSBNADKPCY22S65YXSI.jpg)
U.S. FDA approves Krystal Biotech's skin-disorder gene therapy
The U.S. Food and Drug Administration on Friday approved Krystal Biotech Inc's first-of-its kind topical gene therapy for patients with a genetic skin disorder, sending its shares up 7% in afternoon trading.
Source: reuters.com